BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36213324)

  • 21. ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.
    Lin L; Li X; Pan C; Lin W; Shao R; Liu Y; Zhang J; Luo Y; Qian K; Shi M; Bin J; Liao Y; Liao W
    Cell Death Dis; 2019 Feb; 10(3):173. PubMed ID: 30787271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
    Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
    J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1/Rad51 in gastric cancer.
    Wang Q; Huang C; Wang D; Tao Z; Zhang H; Zhao Y; Wang M; Zhou C; Xu J; Shen B; Zhu W
    Cell Signal; 2023 Jun; 106():110639. PubMed ID: 36842523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway.
    Li H; Shen X; Ma M; Liu W; Yang W; Wang P; Cai Z; Mi R; Lu Y; Zhuang J; Jiang Y; Song Y; Wu Y; Shen H
    J Exp Clin Cancer Res; 2021 Oct; 40(1):340. PubMed ID: 34706747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MACC1 regulates PDL1 expression and tumor immunity through the c-Met/AKT/mTOR pathway in gastric cancer cells.
    Tong G; Cheng B; Li J; Wu X; Nong Q; He L; Li X; Li L; Wang S
    Cancer Med; 2019 Nov; 8(16):7044-7054. PubMed ID: 31557409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway.
    Wei S; Wang L; Zhang L; Li B; Li Z; Zhang Q; Wang J; Chen L; Sun G; Li Q; Xu H; Zhang D; Xu Z
    Tumour Biol; 2016 Sep; 37(9):12813-12821. PubMed ID: 27449034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
    Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
    J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
    Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
    Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
    J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronan-mediated motility receptor confers resistance to chemotherapy
    Zhang H; Ren L; Ding Y; Li F; Chen X; Ouyang Y; Zhang Y; Zhang D
    FASEB J; 2019 May; 33(5):6365-6377. PubMed ID: 30802150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.
    Zhang XB; Song L; Wen HJ; Bai XX; Li ZJ; Ma LJ
    Tumour Biol; 2016 Jun; 37(6):8317-25. PubMed ID: 26729197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
    Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
    Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway.
    Peng YK; Pu K; Su HX; Zhang J; Zheng Y; Ji R; Guo QH; Wang YP; Guan QL; Zhou YN
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1142-1151. PubMed ID: 32096170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.
    Wang X; Gao S; Xie F; Li W; Li M; Yan N; Gao T; Fang L
    J Cell Biochem; 2019 Aug; 120(8):13903-13911. PubMed ID: 30982999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem Cells.
    Wang Q; Huang C; Ding Y; Wen S; Wang X; Guo S; Gao Q; Chen Z; Zhao Y; Wang M; Shen B; Zhu W
    Front Immunol; 2022; 13():884373. PubMed ID: 35572560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer.
    Xu W; Wei Q; Han M; Zhou B; Wang H; Zhang J; Wang Q; Sun J; Feng L; Wang S; Ye Y; Wang X; Zhou J; Jin H
    Int J Biol Sci; 2018; 14(9):1054-1066. PubMed ID: 29989092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Her3 is associated with poor survival of gastric adenocarcinoma: Her3 promotes proliferation, survival and migration of human gastric cancer mediated by PI3K/AKT signaling pathway.
    Wu X; Chen Y; Li G; Xia L; Gu R; Wen X; Ming X; Chen H
    Med Oncol; 2014 Apr; 31(4):903. PubMed ID: 24623015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CLEC5A promotes the proliferation of gastric cancer cells by activating the PI3K/AKT/mTOR pathway.
    Wang Q; Shi M; Sun S; Zhou Q; Ding L; Jiang C; Bian T; Jia F; Liu Y; Qin J
    Biochem Biophys Res Commun; 2020 Apr; 524(3):656-662. PubMed ID: 32033754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. hsa_circ_0000520 influences herceptin resistance in gastric cancer cells through PI3K-Akt signaling pathway.
    Lv X; Li P; Wang J; Gao H; Hei Y; Zhang J; Li S
    J Clin Lab Anal; 2020 Oct; 34(10):e23449. PubMed ID: 32701211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of STIL suppresses the progression of gastric cancer by down-regulating the IGF-1/PI3K/AKT pathway.
    Wang J; Zhang Y; Dou Z; Jiang H; Wang Y; Gao X; Xin X
    J Cell Mol Med; 2019 Aug; 23(8):5566-5575. PubMed ID: 31187582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.